- Statement of Ownership (SC 13G)
08 Giugno 2012 - 4:11PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
China Nuokang
Bio-Pharmaceutical Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
16949B113
(CUSIP Number)
May 25, 2012
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
This Schedule is filed pursuant to Rule 13d-1(c)
The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be
filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
CUSIP NO.
16949B113
|
|
|
|
|
1)
|
|
Name of Reporting Person
|
|
Seligman Spectrum Focus (Master) Fund
|
|
|
S.S. or I.R.S. Identification
|
|
IRS No. 98-0498128
|
|
|
No. of Above Person
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2)
|
|
Check the Appropriate Box
|
|
(a)
|
|
|
if a Member of a Group
|
|
(b) X
|
|
|
|
|
|
|
|
|
|
|
|
3)
|
|
SEC Use Only
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4)
|
|
Citizenship or Place of Organization
|
|
Cayman Islands
|
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH
|
|
|
|
5)
|
|
Sole Voting Power
|
|
-0-
|
6)
|
|
Shared Voting Power
|
|
987,028
|
7)
|
|
Sole Dispositive Power
|
|
-0-
|
8)
|
|
Shared Dispositive Power
|
|
987,028
|
|
|
|
|
|
|
|
|
|
|
|
9)
|
|
Aggregate Amount Beneficially
|
|
|
|
|
Owned by Each Reporting Person
|
|
987,028
|
|
|
|
|
|
|
|
|
|
|
|
10)
|
|
Check if the Aggregate Amount in
|
|
|
|
|
Row (9) Excludes Certain Shares
|
|
Not Applicable
|
|
|
|
|
|
|
|
|
|
|
|
11)
|
|
Percent of Class Represented by
|
|
|
|
|
Amount In Row (9)
|
|
5.02%
|
|
|
|
|
|
|
|
|
|
|
|
12)
|
|
Type of Reporting Person
|
|
CO
|
|
|
|
1(a)
|
|
Name of Issuer:
|
|
China Nuokang Bio-Pharmaceutical Inc.
|
|
|
|
1(b)
|
|
Address of Issuers Principal
|
|
No18 East Nanping Rd.
|
|
|
Executive Offices:
|
|
Shenyang, Liaonnig 110171, China
|
|
|
|
|
|
2(a)
|
|
Name of Person Filing:
(Fund)
|
|
Seligman Spectrum Focus (Master) Fund
|
|
|
|
2(b)
|
|
Address of Principal Business Office:
|
|
P.O. Box 309
|
|
|
|
|
Ugland House, South Church Street
|
|
|
|
|
George Town, Grand Cayman KY1-1104,
|
|
|
|
2(c)
|
|
Citizenship:
|
|
Cayman Islands
|
|
|
|
2(d)
|
|
Title of Class of Securities:
|
|
Common Stock
|
|
|
|
2(e)
|
|
Cusip Number:
|
|
16949B113
|
|
|
3
|
|
This statement is being filed pursuant to §§240.13d-1(c).
|
|
|
4
|
|
Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.
|
|
|
5
|
|
Ownership of 5% or Less of a Class: Not Applicable
|
|
|
6
|
|
Ownership of more than 5% on Behalf of Another Person: Not Applicable
|
|
|
7
|
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:
|
|
|
|
|
Not Applicable
|
|
|
8
|
|
Identification and Classification of Members of the Group:
|
|
|
|
|
Not Applicable
|
|
|
9
|
|
Notice of Dissolution of Group:
|
|
|
|
|
Not Applicable
|
|
|
10
|
|
Certification:
|
|
|
|
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were
not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or
effect.
|
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: June 8, 2012
Seligman Spectrum Focus (Master) Fund
By:
/s/ Eric Brandt
Name: Eric Brandt
Title: Authorized Person
Grafico Azioni China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ:NKBP)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ:NKBP)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NASDAQ): 0 articoli recenti
Più Articoli Notizie